Seize underutilized opportunity to treat glaucoma during vitrectomy

Ophthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.

EP. 1: EyeCon 2022: Nothing is better than in-person conferences

Co-chairs Peter J. McDonnell, MD, director of the Wilmer Eye Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland, and Oluwatosin U. Smith, MD, of Glaucoma Associates of Texas in Dallas break down the top reasons to attend this year's Ophthalmology Times® EyeCon 2022 in a series of video segments.

Last patients complete final visit in NCX 470 Phase 3 Mont Blanc glaucoma trial

According to Nicox SA, the patients made their final 3-month visit last week. Topline results of the trial are expected in November.

BU researcher receives BrightFocus award

September 12, 2022

Haiyan Gong, MD, PhD, professor of ophthalmology and anatomy and neurobiology at Boston University School of Medicine, has received $200,000 through a Standard Award in National Glaucoma Research from the BrightFocus Foundation.

Study focuses on technology to unveil optical texture and trajectories of the axonal fiber bundles on retina

September 12, 2022

A research team led by the Department of Ophthalmology, School of Clinical Medicine, LKS Faculty of Medicine of The University of Hong Kong, with collaborators from the Faculty of Medicine of The Chinese University of Hong Kong and local and international partners, have developed a new technology ROTA to unveil the optical texture and trajectories of the axonal fiber bundles on the retina.

Iantrek raises $23 million in Series B financing for development of MIGS devices in US

August 31, 2022

The first cases in the United States using the company’s suprachoroidal technology were performed earlier this month, and long-term clinical outcomes will be presented at the annual meeting of the American Academy of Ophthalmology in Chicago, starting Sept. 30.